-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Pharvaris (NASDAQ:PHVS) stock moved upwards by 19.4% to $36.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.0 billion.
  • CalciMedica (NASDAQ:CALC) shares rose 13.14% to $1.21. The company's market cap stands at $6.9 million.
  • Roivant Sciences (NASDAQ:ROIV) shares moved upwards by 9.59% to $38.27. The market value of their outstanding shares is at $25.0 billion.
  • Stablecoin Development (AMEX:SDEV) stock rose 8.68% to $0.9. The company's market cap stands at $22.7 million.
  • Tonix Pharmaceuticals (NASDAQ:TNXP) shares moved upwards by 8.65% to $6.28. The company's market cap stands at $98.2 million.
  • Advanced Biomed (NASDAQ:ADVB) shares increased by 8.42% to $4.12. The company's market cap stands at $6.7 million.

Losers

  • Alpha Teknova (NASDAQ:TKNO) stock declined by 29.4% to $5.22 during Wednesday's pre-market session. The company's market cap stands at $365.0 million.
  • IRulya Therapeutics (NASDAQ:IRLA) stock decreased by 19.13% to $32.57. The market value of their outstanding shares is at $35.0 million.
  • SCWorx (NASDAQ:WORX) shares decreased by 11.19% to $3.25.
  • Accendra Health (NYSE:ACH) stock declined by 9.95% to $0.23. The market value of their outstanding shares is at $16.8 million.
  • CytoSorbents (NASDAQ:CTSO) shares fell 9.78% to $4.8. The market value of their outstanding shares is at $15.6 million.
  • Xtant Medical Holdings (AMEX:XTNT) stock decreased by 7.03% to $0.28. The market value of their outstanding shares is at $40.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending